Subscribe: Untitled
http://rss.prnewswire.com/geography/MI
Preview: Untitled

PR Newswire:



PR Newswire: All Press Releases



Published: Fri, 23 Jun 2017 03:09:08 EDT

Last Build Date: Fri, 23 Jun 2017 03:02:00 EDT

 



Giant Panda in Hand with Koala - Chengdu and Australia Promote Bilateral Cooperation on Tourism and Trade

Fri, 23 Jun 2017 03:02:00 EDT

CHENGDU, China, June 23, 2017 /PRNewswire/ -- On June 18, local time of Australia, the inauguration ceremony of "2017 China-Australia Tourism Year - Theme Activity Day of Chengdu City" was held at Federation Square, Melbourne, Australia. Through setting up three theme activities including...



Verimatrix Underscores Commitment to Verspective Operator Analytics through Device-Level Data Collection Acquisition

Fri, 23 Jun 2017 03:00:00 EDT

(image) SAN DIEGO, June 23, 2017 /PRNewswire/ -- Verimatrix, the specialist in securing and enhancing revenue for multi-network, multi-screen digital TV services around the globe, today announced the acquisition of the MiriMON technology and development team from Genius Digital, the expert in...



Media Files:
https://mma.prnewswire.com/media/492756/Verimatrix_Logo.jpg




Jeff Rumburg of MetricNet Shares Predictions for the Future of Service and Support

Fri, 23 Jun 2017 03:00:00 EDT

(image) MCLEAN, Va., June 23, 2017 /PRNewswire/ -- MetricNet is pleased to announce that Jeff Rumburg, Managing Partner of MetricNet, LLC and one of HDI's Top 25 Thought Leaders for 2016, was recently interviewed by Amy Eisenberg, HDI's editor. A leading source for professional...



Media Files:
https://mma.prnewswire.com/media/526967/MetricNet_Logo.jpg




Personetics Co-founder and CEO to Discuss 'Adventures in AI: Use Cases in Financial Services' at Money20/20 Europe

Fri, 23 Jun 2017 03:00:00 EDT

(image) COPENHAGEN, Denmark, June 23, 2017 /PRNewswire/ -- David Sosna, co-founder and chief executive officer at Personetics, the leading provider of cognitive applications for the financial services sector, will participate in a panel of financial experts discussing use cases for AI in...



Media Files:
http://mma.prnewswire.com/media/466622/Personetics_Logo.jpg




Verimatrix unterstreicht mit Kauf eines Dienstes zur Datenerhebung auf Geräteebene sein Engagement für Verspective Operator Analytics

Fri, 23 Jun 2017 03:00:00 EDT

(image) Ermittlung von Sicherheitsdaten auf Geräten in Echtzeit als Schlüssel zur Abgrenzung von der Konkurrenz in der Analysebranche erkannt SAN DIEGO, 23. Juni 2017 /PRNewswire/ -- Verimatrix, der Spezialist für die Absicherung und die Steigerung der Umsätze von digitalen...



Media Files:
http://mma.prnewswire.com/media/492756/Verimatrix_Logo.jpg




Novartis pivotal CTL019 6-month follow-up data show durable remission rates in children, young adults with r/r B-cell ALL

Fri, 23 Jun 2017 02:41:00 EDT

EAST HANOVER, N.J., June 23, 2017 /PRNewswire/ -- Novartis today announced updated results from the ELIANA clinical trial demonstrating CTL019 (tisagenlecleucel) remission rates are maintained at six months in relapsed/refractory (r/r) pediatric and young adult patients with B-cell acute...



De hoofdstedelijke regering van Tokio nodigt buitenlandse bedrijven uit om deel te nemen aan FinTech Business Camp Tokyo

Fri, 23 Jun 2017 02:39:00 EDT

TOKIO, 23 juni 2017 /PRNewswire/ -- De hoofdstedelijke regering van Tokio (TMG - Tokyo Metropolitan Government) bereidt een nieuw plan voor dat aangeduid kan worden als de "Financiële systeemhervorming van Tokio -- Tokio's oerknal", om de status als belangrijkste...



PPAM SOLKRAFT Collaborates with Solar Technology Leader to become Sunpreme Channel Partner - Promoting Bifacial PV Panels

Fri, 23 Jun 2017 02:33:00 EDT

(image) SAN FRANCISCO, June 23, 2017 /PRNewswire/ -- PPAM SOLKRAFT, the Sweden based solar developer and installer, has joined Sunpreme Channel network — a strategic partnership program designed to deliver the most advanced solar products and superior engineering to residential, carports and...



Media Files:
http://www.sunpreme.com




European Hematology Association: Treating Sickle Cell Disease and Beta-Thalassemia with CRISPR/Cas9 Gene Editing

Fri, 23 Jun 2017 02:30:00 EDT

(image) MADRID, June 23, 2017 /PRNewswire/ -- Sickle Cell Disease and Beta-thalassemia are two severe diseases that are caused by defects in the beta-globin protein in hemoglobin, present in red blood cells. Patients born with Sickle Cell Disease and Beta-thalassemia do not have symptoms...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




European Hematology Association: Shedding New Light on the Prevention of Platelet Storage Lesion

Fri, 23 Jun 2017 02:30:00 EDT

(image) MADRID, June 23, 2017 /PRNewswire/ -- Hemorrhagic and thrombocytopenic patients require platelet transfusion to prevent or treat bleeding. Cold storage of platelets results in complex molecular lesions associated with changes in platelet membrane microdomains that are recognized by...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




European Hematology Association: Delayed Exposure to Common Infections Causes Acute Leukemia of Childhood

Fri, 23 Jun 2017 02:30:00 EDT

(image) MADRID, June 23, 2017 /PRNewswire/ -- Acute leukemia is the most common cancer in childhood and the incidence is increasing especially in socio economic advanced countries. Infection as a trigger of leukemia development in children has been controversially discussed since decades and...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




European Hematology Association: Two is better than one: The Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Rapid Tumor Responses in a Phase 2 Study for Relapsed/Refractory NHL

Fri, 23 Jun 2017 02:30:00 EDT

(image) MADRID, June 23, 2017 /PRNewswire/ -- Cerdulatinib is an oral, dual Syk-JAK inhibitor with a unique mechanism of action. It inhibits two key signaling pathways that promote cancer cell growth in certain hematologic malignancies: the B-cell receptor pathway via Syk and key cytokine...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




European Hematology Association: The More the T-lymphocytes Differ, the More Effectively They Fight Against Leukemia

Fri, 23 Jun 2017 02:30:00 EDT

(image) MADRID, June 23, 2017 /PRNewswire/ -- Adult patients with relapsed or refractory B-cell acute lymphoblastic leukaemia (r/r ALL) have a poor prognosis despite intense salvage treatments. Recent reports have shown that Blinatumomab (Blin) can induce high remission rates in these...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




L'association européenne d'hématologie-European Hematology Association : soigner la maladie drépanocytaire et la bêta-thalassémie avec l'édition génomique CRISPR/Cas9

Fri, 23 Jun 2017 02:30:00 EDT

(image) MADRID, June 23, 2017 /PRNewswire/ -- La maladie drépanocytaire et la bêta-thalassémie sont deux maladies graves provoquées par des déficits de la protéine de globine bêta dans l'hémoglobine, présente dans les globules rouges. Les patients nés avec la maladie drépanocytaire et la...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




European Hematology Association: La exposición retrasada a las infecciones comunes causa leucemia aguda en la infancia

Fri, 23 Jun 2017 02:30:00 EDT

(image) MADRID, June 23, 2017 /PRNewswire/ -- La leucemia aguda es el tipo de cáncer más común en la infancia, y su incidencia está aumentando, sobre todo en los países socio-económicamente avanzados. Las infecciones como desencadenante del desarrollo de la leucemia en niños se ha debatido...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




Association européenne d'hématologie : plus les lymphocytes T sont différents, plus efficacement ils luttent contre la leucémie

Fri, 23 Jun 2017 02:30:00 EDT

(image) MADRID, June 23, 2017 /PRNewswire/ -- Les patients adultes souffrant de leucémie lymphoblastique aigüe à cellules B récidivante ou réfractaire (ALL r/r) ont un pronostic médiocre en dépit de traitements intenses de récupération. De récents rapports ont démontré que le Blinatumomab...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




Association européenne d'hématologie : une exposition retardée aux infections communes provoque la leucémie infantile aigüe

Fri, 23 Jun 2017 02:30:00 EDT

(image) MADRID, June 23, 2017 /PRNewswire/ -- La leucémie aigüe est le cancer le plus fréquent chez l'enfant et l'incidence augmente, surtout dans les pays avancés sur le plan socio-économique. L'infection comme déclencheur du développement de la leucémie chez les enfants fait l'objet d'un...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




Association européenne d'hématologie : deux valent mieux qu'un : le double inhibiteur SYK / JAK cerdulatinib démontre des réponses rapides aux tumeurs dans une étude de phase II portant sur le lymphome non hodgkinien récidivant / réfractaire

Fri, 23 Jun 2017 02:30:00 EDT

(image) MADRID, June 23, 2017 /PRNewswire/ -- Le cerdulatinib est un inhibiteur double et oral Syk-JAK qui présente un seul mécanisme d'action. Il inhibe deux voies de signalisation clés qui favorisent la croissance des cellules cancéreuses dans certaines tumeurs malignes hématologiques : la...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




European Hematology Association: Cuanto más difieren los linfocitos T, mejor luchan contra la leucemia

Fri, 23 Jun 2017 02:30:00 EDT

(image) MADRID, June 23, 2017 /PRNewswire/ -- Los pacientes adultos con leucemia linfoblástica aguda de célula B refractario o en recaída (r/r ALL) tienen un pronóstico pobre a pesar de los intensivos intentos de rescate. Los informes recientes han demostrado que Blinatumomab (Blin) puede...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg




European Hematology Association: Beziehung zwischen verspäteter Exposition mit üblichen Infektionen und akuter Leukämie bei Kindern

Fri, 23 Jun 2017 02:30:00 EDT

(image) MADRID, June 23, 2017 /PRNewswire/ -- Akute Leukämie ist die häufigste Krebsart bei Kindern. Insbesondere in sozioökonomisch fortgeschrittenen Ländern nimmt die Inzidenz zu. Seit Jahrzehnten werden Infektionen als Auslöser einer Leukämie bei Kindern kontrovers diskutiert. Die...



Media Files:
http://mma.prnewswire.com/media/524821/EHA_Logo.jpg